These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1680447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Chung WW, Leung CB, Chan K, Lai KN.
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 Jan; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L.
    Adv Perit Dial; 1991 Jan; 7():296-300. PubMed ID: 1680450
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I, Schollmeyer P, Steinhauer HB.
    Adv Perit Dial; 1990 Jan; 6():302-7. PubMed ID: 1982833
    [Abstract] [Full Text] [Related]

  • 14. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Jan; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Di Paolo B, Marini A, Fiederling B, Di Liberato L, Santarelli P, Bucciarelli S, Stuard S, Paolantonio L, Albertazzi A.
    Perit Dial Int; 1993 Jan; 13 Suppl 2():S538-40. PubMed ID: 8399659
    [Abstract] [Full Text] [Related]

  • 17. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
    Vega N, Fernandez A, Hortal L, Macias M, Rodriguez JC, Plaza C, Perdomo M, Vega R, Palop L.
    Adv Perit Dial; 1992 Jan; 8():467-70. PubMed ID: 1361850
    [Abstract] [Full Text] [Related]

  • 18. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L.
    Adv Perit Dial; 1990 Jan; 6():296-301. PubMed ID: 1982831
    [Abstract] [Full Text] [Related]

  • 19. Iron dextran treatment in peritoneal dialysis patients on erythropoietin.
    Suh H, Wadhwa NK.
    Adv Perit Dial; 1992 Jan; 8():464-6. PubMed ID: 1361849
    [Abstract] [Full Text] [Related]

  • 20. The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A.
    Adv Perit Dial; 1997 Jan; 13():109-12. PubMed ID: 9360661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.